Jeremy Smith

Jeremy Smith is an experienced healthcare investor currently serving as an Associate at LetterOne since July 2022, focusing on Healthtech, Medtech, Pharma Services, and Healthcare Services across Europe, North America, and the Middle East. Prior to this role, Jeremy worked as an Investment Banking Analyst at Rothschild & Co and Silverpeak LLP, contributing to healthcare teams. As a Co-Founder of Nanomed from October 2016 to August 2018, Jeremy developed innovative drug delivery methods using carbon nanostructures for oncology treatments and secured a place in the BioStars accelerator at Oxford University. Education includes a Master of Research in Graphene Technology and a Master of Philosophy in Micro- and Nanotechnology Enterprise from the University of Cambridge, along with a Bachelor's degree in Materials Science from Imperial College London.